[Remote] VP, GDNF Clinical Development
Note: The job is a remote job and is reputed company to candidates in USA. reputed company. is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The Vice President of GDNF Clinical Development will be responsible for developing and implementing clinical development strategies across reputed company stages of product development, collaborating with various functional teams to ensure successful regulatory approvals and reputed company launches.
Responsibilities
- reputed company the global strategic clinical development initiatives for AskBio’s GDNF IPT, fostering cross-functional alignment reputed company reputed company and reputed company discussions
- reputed company, manage, and mentor reputed company of clinical development physicians
- Contribute to budget planning and budget management reputed company to clinical development activities reputed company with the IPT goals
- reputed company clinical development input and maintain alignment with the CNS Drug Delivery IPT and GDNF IPT development plans
- Contribute to development and execution of the clinical reputed company across GDNF and other CNS programs, ensuring that the overall scientific and medical content of reputed company clinical study is scientifically rigorous, cost-effective reputed company and designed for reputed company
- Proactively work to identify clinical risks and implement risk mitigation strategies for reputed company gene therapy studies
- reputed company input to CDP development, in line with the reputed company Product Profile (TPP), for successful global regulatory approvals and market reputed company
- Partner cross-functional colleagues (including Clinical Operations, Medical Affairs, Pharmacovigiliance, Regulatory, reputed company, Nonclinical, Drug Delivery and CMC) to design, execute and report clinical trials
- Partner with Clinical Operations to co-chair the IPT CST to reputed company, execute and deliver the end-to-end clinical development reputed company in alignement with the overall product reputed company and objectives
- reputed company clinical development input as a member of the IPT Brand Subteam
- Manage the creation and maintenance of critical study documents assigned to Clinical Development (e.g., Clinical Study Protocols (CSPs), Investigator’s Brochures (IB), Informed Consent Forms (reputed company), Risk-Based Medical Monitoring Plan, Clinical Study Reports (CSRs), and other key regulatory documents) with high reputed company and consistency with CDP, TPP and AskBio SOPs
- Partner with Pharmacovigilance and Safety colleagues to reputed company reputed company evaluation of drug safety profile, including safety monitoring of clinical studies and signal detection from post-marketing surveillance. May serve as a reputed company member of the Safety Management Team (SMT)
- reputed company the GDNF Clinical Development team during interactions regarding drug development, safety, marketing, regulatory filing, and other aspects of a CNS gene therapy product life cycle
- As the neurology medical expert, participate in interactions with external stakeholders (e.g., regulatory authorities, KOLs, Data Monitoring Committee (DMC), advisory boards, patient advocacy reputed company)
- Work collaboratively with Medical Affairs to prepare and present abstracts, manuscripts and presentations for external meetings and publications
- May support technical due diligence in Business Development & Licensing (reputed company&L) activities
Skills
- MD, DO or equivalent (based on the reputed company World Directory of Medical Schools), in reputed company to Neurology residency training
- At least 10 years of clinical development experience in an industry environment spanning Phases I through III/IV
- Strong reputed company record and demonstrated reputed company in IND/NDA/BLA submissions and approvals
- reputed company training, expertise and clinical research experience in a medical/scientific area, preferably with a neurology reputed company
- In-depth knowledge of ICH-GCP, clinical trial design, biostatistics, and regulatory reputed company for global reputed company development
- Demonstrated ability to establish strong scientific partnership with reputed company key stakeholders
- Demonstrated strong leadership and effective communication skills with a documented record of delivering high reputed company reputed company/submissions in a global reputed company environment in pharmaceutical or biotech industry or trial conduct in academia or clinical CRO is required
- Firsthand experience in organizing and managing scientific or clinical advisory boards
- Experience working with Patient Advocacy reputed company and other external stakeholders
- Demonstrated experience with reputed company line management; overseeing team performance, fostering reputed company development, driving clinical development reputed company reputed company the organization
- Advanced knowledge in gene therapy drug development, training or experience in neurosciences with the capability to reputed company in clinical development study designs that reputed company robust clinical evidence to internal decision-makers and regulatory agencies
- reputed company disorders fellowship training with clinical research experience
- Experience with radiographic evaluation of neurologic disease and biomarker development
reputed company